Skip to content
Recall Observatory FDA recall evidence

Drug product

Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY NDC 0555-9051-67

D-1439-2014

June 17, 2014

Class III

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 68610
Status
Terminated
Classification
Class III
Quantity
5265 blister packs
Official record key
drug-enforcement:D-1439-2014

Official wording

Reason: Failed Impurities/Degradation Specifications: out of specification impurity test results.

Code information: Lot 33805449A, Exp. 12/14

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification